SCHEMBL6780469

SCHEMBL6780469

CCc1cc(O)c2c3c(C(N)=O)cccc3n(Cc3ccccc3C(F)(F)F)c2c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.41
CD38 P28907 1/20 0.41
KIF11 P52732 8/20 0.40
PARP1 P09874 1/20 0.40
RORC P51449 2/20 0.40
CYP2C9 P11712 3/20 0.39
AURKA O14965 1/20 0.38
RPS6KB1 P23443 1/20 0.38
AURKB Q96GD4 1/20 0.38
FABP3 P05413 1/20 0.38
FABP4 P15090 1/20 0.38
EPHX2 P34913 1/20 0.37
PPARG P37231 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
PTGES O14684 1/20 0.37
PIK3C2B O00750 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.36
C5AR1 P21730 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6895550 0.90 KIF11 (0.42) KIF11RORCCYP2C9FABP3FABP4
SCHEMBL6777171 0.90 CYP3A4 (0.38) CYP3A4CD38KIF11PARP1RORC
SCHEMBL6774832 0.88 CD38 (0.44) CYP3A4CD38KIF11PARP1RORC
SCHEMBL6773681 0.87 ALDH1A1 (0.42) AURKARPS6KB1FABP3
SCHEMBL6692824 0.87 AURKA (0.43) CYP3A4CD38KIF11PARP1RORC
SCHEMBL6782082 0.86 RORC (0.42) CYP3A4CD38KIF11PARP1RORC
SCHEMBL6780594 0.86 MEN1 (0.43) CD38PARP1AURKARPS6KB1TDP1
SCHEMBL6775269 0.86 CYP3A4 (0.40) CYP3A4CD38KIF11PARP1RORC
SCHEMBL6771810 0.85 ALDH1A1 (0.42) CYP3A4CD38CYP2C9TDP1
SCHEMBL6776238 0.85 CD38 (0.38) CD38PARP1AURKARPS6KB1SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed